Samsung Display Co., Ltd.

Samsung Electronics Co., Ltd.

Lg Electronics Inc.

Kine Sciences Co., Ltd.

Amorepacific Corporation

Bio Pep Co., Ltd.

Lg Innotek Co., Ltd.

Yonsei University

Samsung Mobile Display Co., Ltd.

Korea Research Institute of Chemical Technology

Nhn Corporation

Sk Biopharmaceuticals Co., Ltd.

Cj Healthcare Corporation

Netmarble Corporation

Hk Inno.n Corporation

Sun Young Park

Yul-Kyu Lee

Chun-Gi You

Jong-Hyun Park

Jin-Hee Kang

Kyu-Sik Cho

Kyung-Hoon Park

Sang-Ho Moon

Bon Kwon Koo

Sang Wook Hong

Kyu Sung Kim

Han Bit Kim

Ji Hyun Kim

Dae Ho Cho

Dae-Woo Kim

Jae Won Chang

Ji Hee Kim

Yu Sic Kim

Chungi You

Myung Jin Jung

Hui Chul Yang

Jin Yong Kim

Joon-Hoo Choi

Tae-Ho Kim

Ji Hye Kim

Sung Jun Kim

Dong Woo Lee

Na-Young Kim

June-Woo Lee

Jin Young Lee

Ki-Nyeng Kang

Do-Hyung Ryu

Dong Gyu Kim

Bo-Kyung Choi

Jeong Hwan Kim

Hyuk Hwan Kim

Seong-jun Park

Su Jin Park

Tae Ryong Lee

Seung Woo Shin

Min Chul Shin

In Won Jong

Ji-Hoon Song

Kyung Eun Kim

Jee Yeun Wang

Yul Kyu Lee

Hyun Su Hong

Sang Su Lee

Jun Oh Kim

Dong Hyun Ko

Hyoung June Kim

Yeong-Ho Song

Ki Young Kang

Seung Il Kim

Ji Wook Moon

Tae Won Um

Joong Hun Kwon

Yong Duck Son

Sung-Jae Moon

Wonho Jang

Myun Soo Kim

Chang Kwon Park

Kwang-Hae Kim

Kyung Hwa Kim

Chul Wee Lee

Jung Yeob Oh

Won Seok Park

Hyung Jun Lim

Eun Joo Kim

Soo Yeon Jung

Myeong Lo Lee

Woo Jin Jung

Jeong Gwan Kang

Soon Ae An

Joohyeon Jo

Il Hwan Seo

Young Mee Chung

Jin Wook Jeong

Sung Yeon Cho

Seung Chan Kim

Myung Koo Hur

Sang Hun Han

Eun-Gyung Cho

Chan Woo Lee

Eui Dong Son

Seog Beom Song

Sung Hoon Lee

Hyun Goo Kang

Hyo Il Jung

Ki Ho Hong

Byung Jun Lee

Mi Young Yoon

Nak Hyun Choi

Kyu Han Kim

Chi Hye Park

Seung Hyuck Shin

Mi Suk Eom

Sook Kyung Park

Kuk-Jin Kang

Yun Hwa Seo

An imaging apparatus includes an imaging element, an imaging driver, a controller, and a memory. The imaging driver is configured to drive the imaging element. The controller is configured to detect a flicker in an image captured by the imaging apparatus. The memory is configured to, in response to the flicker being detected, store data on a characteristic of the flicker, a first frame rate, and a first shutter speed of the imaging element.

Imaging apparatus and method of controlling the same

A display apparatus includes a substrate including a display area and a peripheral area, a thin film transistor including a semiconductor layer, a gate electrode, a source electrode, and a drain electrode, a first inorganic insulating layer located on the substrate and under the gate electrode and covering the semiconductor layer, a second inorganic insulating layer located on the first inorganic insulating layer and covering the gate electrode, a third inorganic insulating layer located on the second inorganic insulating layer and including a 1-3th opening in the peripheral area, an organic insulating layer located on the third inorganic insulating layer, covering the source electrode and the drain electrode, and including a second opening overlapping the 1-3th opening in the peripheral area, and a pattern portion located on a layer under the organic insulating layer and overlapping the 1-3th opening and the second opening.

Display apparatus

A display device includes a substrate that includes a display area and a non-display area; a mask support that is disposed in the non-display area of the substrate; a sealant that is disposed in the non-display area of the substrate and is disposed between the mask support and the display area; an insulating layer that is disposed between the sealant and the mask support; and a plurality of grooves that are formed by removing at least a part of the insulating layer.

Display device

A method for providing training for treating emergency patients is provided. The method for providing treatment training for an emergency patient comprises the steps of: generating a virtual patient scored according to the virtual patient's conditions on the basis of medical statistics; automatically allocating necessary treatment data on the basis of vital signs of the generated virtual patient; providing a user with the generated virtual patient and the vital signs on the basis of augmented reality by using a user terminal; receiving, at the user terminal, the result of treatment performed by the user on the basis of the vital signs of the virtual patient; and providing evaluation data by comparing the result of treatment performed by the user with the treatment data for the virtual patient.

Method and apparatus for providing training for treating emergency patients

A display panel includes: a first gate line extending in a first direction; a second gate line extending in the first direction and spaced apart from the first gate line in a second direction crossing the first direction; a first connection line extending in the second direction; and a second connection line extending in the second direction and spaced apart from the first connection line in the first direction, wherein a distal end of the first connection line overlaps the first gate line and is electrically connected to the first gate line, and wherein a distal end of the second connection line overlaps the second gate line and is electrically connected to the second gate line.

Display panel

The present invention relates to a microfluidic mixer and a microfluidic device including the same, and in the microfluidic mixer according to the present invention, a disk-shaped mixing unit with double U-shaped protruding portions formed therein can be continuously provided along a microchannel, thereby increasing collisions of samples to improve the binding efficiency thereof and shorten the binding time. Furthermore, the microfluidic device according to the present invention can detect a target material at high speed even at a high flow rate by including the microfluidic mixer, and thus can be usefully utilized for early diagnosis and prognosis diagnosis of a disease such as cancer.

Microfluidic mixer and microfluidic device comprising the same

The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, reduce the secretion of inflammatory cytokine IL-6, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

A power conditioning system (PCS) includes: a grid blackout determiner, a voltage controller, and a processor electrically connected to the grid blackout determiner and the voltage controller. The processor is configured to identify a state of a grid as a blackout state or an unstable state based on at least one of an amplitude or a frequency of a voltage of the grid that is detected by the grid blackout determiner, control the voltage controller to adjust, based on the identified state of the grid being the blackout state or the unstable state, load voltage input to the voltage controller to be equal to a command voltage, and adjust, based on the identified state of the grid being the blackout state or the unstable state, a first frequency of the detected voltage of the grid to a second frequency that is different from the first frequency.

Power conditioning system and method

The present invention relates to use of peptides as a therapeutic agent, wherein it has been confirmed that the peptides of the present invention significantly inhibit the activity of T cells and the differentiation of T helper 17 cells (Th17 cells), which are associated with autoimmune disease, and have remarkable effects of treating and improving arthritis in an animal model of arthritis. Therefore, the peptides may be used as an active ingredient in therapeutic agents for various autoimmune diseases such as bone disease, inflammatory disease or rheumatoid arthritis.

The present invention relates to a novel formulation comprising a benzimidazole derivative. The formulation for oral administration comprising a compound of Formula 1 according to the present invention or a pharmaceutically acceptable salt thereof; and at least one disintegrant selected from the group consisting of croscarmellose sodium, sodium starch glycolate and low-substituted hydroxypropylcellulose, exhibits an excellent storage stability and has an effect on preventing a phenomenon of decline in dissolution rate, thus being usefully used as a formulation for oral administration.

Preparation containing benzimidazole derivative

Disclosed is a game test automation device capable of automating a game test. The game test automation device can comprise: a database for storing test procedure information, which is a combination of game scripts to be tested in a game service; and a testing unit for testing game build of the game service on the basis of the test procedure information, and creating game state information derived in the testing process and a test report on the test.

Game test automation device and method

The present invention relates to a use of a carbamate compound of formula 1, or a pharmaceutically acceptable salt, solvate or hydrate thereof in the prevention or treatment of diseases associated with an increase in late sodium current.

Use of carbamate compound for preventing or treating diseases associated with increase in late sodium current

A method for controlling a screen of a mobile terminal that simultaneously displays a plurality of execution screens is provided. The method preferably includes: displaying a layout composed of a plurality of sections when a magazine creation event is sensed; mapping applications to the plurality of sections in a one-to-one correspondence, respectively to create a magazine; and displaying the magazine, and an execution screen of an application mapped to each of the sections is arranged at the magazine.

Sectional user interface for controlling a mobile terminal

Provided is a novel peptide for preventing or treating inflammatory diseases and a use thereof. According to the novel dimeric or trimeric peptide, it is possible to not only exhibit an excellent therapeutic effect through anti-inflammatory action but also have a very small-sized peptide, thereby minimizing side effects due to the administration of external substances. Therefore, it is expected that the peptide can be used as an active substance that can replace existing therapeutic agents for inflammatory diseases.

Peptide for preventing or treating inflammatory diseases and use thereof

Growing community of inventors

Yongin-si, South Korea

Sun Young Park